Detalles de la búsqueda
1.
New approaches in chimeric antigen receptor T-cell therapy for breast cancer. / åµåæååä½Tç»èçæ³å¨ä¹³è ºçä¸çåºç¨è¿å±.
Zhong Nan Da Xue Xue Bao Yi Xue Ban
; 45(9): 1120-1126, 2020.
Artículo
en Inglés, Zh
| MEDLINE | ID: mdl-33051428
2.
[Progress in endocrine therapy for early breast cancer].
Zhong Nan Da Xue Xue Bao Yi Xue Ban
; 44(11): 1268-1274, 2019 Nov 28.
Artículo
en Zh
| MEDLINE | ID: mdl-31919322
3.
[Expression of chemokine CXCL12 and its receptor (CXCR4 and CXCR7) in different molecular subtypes of human breast carcinoma and the clinical significance].
Zhong Nan Da Xue Xue Bao Yi Xue Ban
; 42(2): 147-153, 2017 Feb 28.
Artículo
en Zh
| MEDLINE | ID: mdl-28255115
4.
[Parecoxib suppresses the increase of neutrophil-to-lymphocyte ratio after the modified radical mastectomy].
Zhong Nan Da Xue Xue Bao Yi Xue Ban
; 42(9): 1048-1052, 2017 Sep 28.
Artículo
en Zh
| MEDLINE | ID: mdl-28989150
5.
[Meta-analysis of endoscopic axillary lymph node dissection versus conventional open excision for breast cancer].
Zhong Nan Da Xue Xue Bao Yi Xue Ban
; 40(7): 782-9, 2015 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-26267692
6.
[A case of Sagliker syndrome and literature review].
Zhong Nan Da Xue Xue Bao Yi Xue Ban
; 39(10): 1100-4, 2014 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-25355264
7.
POU2F2-mediated upregulation of lncRNA PTPRG-AS1 inhibits ferroptosis in breast cancer via miR-376c-3p/SLC7A11 axis.
Epigenomics
; 16(4): 215-231, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38318853
8.
[Meta analysis of efficacy and safety between mammotome minimally invasive operation and open excision for benign breast tumor].
Zhong Nan Da Xue Xue Bao Yi Xue Ban
; 38(3): 291-300, 2013 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-23545825
9.
Corrigendum: Probiotics for the treatment of docetaxel-related weight gain of breast cancer patients-A single-center, randomized, double-blind, and placebo-controlled trial.
Front Nutr
; 10: 1276556, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37674884
10.
Hormone Receptor Expression on Endocrine Therapy in Patients with Breast Cancer: A Meta-Analysis.
Am Surg
; 88(1): 48-57, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33382340
11.
Safety of Breast Cancer Mastoscopic Surgery from the Perspective of Immunity and Adipokines.
J Invest Surg
; 35(3): 632-638, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33998356
12.
Breast cancer combined with contralateral neck lymph node metastasis: a case report.
Diagn Pathol
; 17(1): 60, 2022 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35841040
13.
Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial.
Eur J Cancer
; 161: 10-22, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34896904
14.
Identification of N6-Methyladenosine-Related LncRNAs for Predicting Overall Survival and Clustering of a Potentially Novel Molecular Subtype of Breast Cancer.
Front Oncol
; 11: 742944, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34722294
15.
Probiotics for the Treatment of Docetaxel-Related Weight Gain of Breast Cancer Patients-A Single-Center, Randomized, Double-Blind, and Placebo-Controlled Trial.
Front Nutr
; 8: 762929, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34926547
16.
Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis.
Front Oncol
; 11: 661128, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33747972
17.
ERBB4 promotes the progression of inflammatory breast cancer through regulating PDGFRA.
Transl Cancer Res
; 9(5): 3266-3273, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35117693
18.
UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer.
Theranostics
; 10(4): 1833-1848, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32042339
19.
Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis.
Front Oncol
; 10: 811, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32528890
20.
Impact of CXCR4 and CXCR7 knockout by CRISPR/Cas9 on the function of triple-negative breast cancer cells.
Onco Targets Ther
; 12: 3849-3858, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31190884